跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Betazok - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Betazok
Approved
STANDARD
Betazok
AstraZeneca AB
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
57a54545bf18a71b
Company
AstraZeneca AB
Type
Standard
Approval Details
Approval Id
57a54545bf18a71b
Drug Approval Philippines Name
Betazok
Product Name
Betazok
Registration Number
DR-XY12973
Brand Name
Betazok
Generic Name
Metoprolol Succinate (equivalent to 100 mg Metoprolol Tartrate)
Dosage Form
Controlled-Release Tablet
Dosage Strength
95 mg
Manufacturer
AstraZeneca AB
Company Detail Path
/organization/astrazeneca-ab
Issuance Date
24 September 2024
Expiry Date
24 September 2029
Pharmacologic Category
Beta-adrenoceptor blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
57a54545bf18a71b
Type
Standard
Back to Philippines FDA Approvals